000			01572 a2200385 4500
005			20250518015423.0
264		0	_c20200630
008			202006s 0 0 eng d
022			_a1460-2091
024	7		_a10.1093/jac/dky545 _2doi
040			_aNLM _beng _cNLM
100	1		_aMaiden, Michael M
245	0	0	_aThe ionophore oxyclozanide enhances tobramycin killing of Pseudomonas aeruginosa biofilms by permeabilizing cells and depolarizing the membrane potential. _h[electronic resource]
260			_bThe Journal of antimicrobial chemotherapy _c04 2019
300			_a894-906 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAnti-Bacterial Agents _xpharmacology
650	0	4	_aBiofilms _xdrug effects
650	0	4	_aCell Membrane _xdrug effects
650	0	4	_aChild
650	0	4	_aDrug Synergism
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aMembrane Potentials _xdrug effects
650	0	4	_aMicrobial Viability _xdrug effects
650	0	4	_aOxyclozanide _xpharmacology
650	0	4	_aPermeability _xdrug effects
650	0	4	_aPseudomonas Infections _xmicrobiology
650	0	4	_aPseudomonas aeruginosa _xdrug effects
650	0	4	_aTobramycin _xpharmacology
700	1		_aZachos, Mitchell P
700	1		_aWaters, Christopher M
773	0		_tThe Journal of antimicrobial chemotherapy _gvol. 74 _gno. 4 _gp. 894-906
856	4	0	_uhttps://doi.org/10.1093/jac/dky545 _zAvailable from publisher's website
999			_c29236147 _d29236147